1 Department of Medicine Case Western Reserve University Cleveland OH.
2 Division of Cardiovascular Medicine University Hospitals Cleveland Medical Center Cleveland OH.
J Am Heart Assoc. 2019 May 21;8(10):e011401. doi: 10.1161/JAHA.118.011401.
Background This study assessed the effect of blockading neural transmission in the ganglionated plexi by injecting lidocaine into fat pads in the vagal nerve stimulation canine model and patients with persistent atrial fibrillation ( AF ). Methods and Results An efficacy test of lidocaine injection was performed in 7 canines. During vagal nerve stimulation, AF was sustained for >5 minutes. The lidocaine was injected into ganglionated plexi during sinus rhythm and reinduction of AF was attempted. Six patients with persistent AF were studied at open heart surgery. Lidocaine was injected into ganglionated plexi. Atrial electrograms were recorded from 96 epicardial electrodes covering Bachmann's bundle and atrial appendages. In the canine vagal nerve stimulation AF model, AF was not inducible in 4 of 7 after lidocaine injection. In patients with persistent AF , during baseline AF , there was a left atrium ( LA )-to-right atrium ( RA ) frequency gradient ( LA , mean cycle length [ CL ] 175±17 ms; RA , mean CL 192±17 ms; P<0.01). After lidocaine injection, AF persisted in all patients, and the LA -to- RA frequency gradient disappeared ( LA , mean CL 186±13 ms; RA , mean CL 199±23 ms; P=0.08). Comparison of mean CL s before and after lidocaine demonstrated prolongation of LA CL s ( P<0.05) with no effect on RA CL s. Conclusions In the canine vagal nerve stimulation AF model, lidocaine injection decreased inducibility of AF . In patients with persistent AF , atrial electrograms from the LA had shorter CL s than RA , indicating an LA -to- RA frequency gradient. Lidocaine injection significantly prolonged only LA CL s, explaining disappearance of the LA -to- RA frequency gradient. The mechanism of localized atrial electrogram CL prolongation in patients with persistent AF is uncertain.
背景 本研究通过向迷走神经刺激犬模型和持续性心房颤动(AF)患者的迷走神经脂肪垫内注射利多卡因,评估阻断神经节丛对神经传递的影响。
方法和结果 在 7 只犬中进行了利多卡因注射的疗效测试。在迷走神经刺激期间,AF 持续>5 分钟。在窦性心律时向神经节丛内注射利多卡因,并尝试重新诱发 AF。在心脏直视手术中对 6 例持续性 AF 患者进行了研究。向神经节丛内注射利多卡因。从覆盖 Bachmann 束和心房附件的 96 个心外膜电极记录心房电图。在犬迷走神经刺激 AF 模型中,4/7 只犬在利多卡因注射后不能诱发 AF。在持续性 AF 患者中,在基线 AF 期间,存在左心房(LA)到右心房(RA)的频率梯度(LA,平均周期长度[CL] 175±17 ms;RA,平均 CL 192±17 ms;P<0.01)。在利多卡因注射后,所有患者的 AF 持续存在,LA 到 RA 的频率梯度消失(LA,平均 CL 186±13 ms;RA,平均 CL 199±23 ms;P=0.08)。比较利多卡因注射前后的平均 CL 值显示 LA CL 延长(P<0.05),但对 RA CL 无影响。
结论 在犬迷走神经刺激 AF 模型中,利多卡因注射可降低 AF 的诱发性。在持续性 AF 患者中,LA 的心房电图 CL 短于 RA,表明存在 LA 到 RA 的频率梯度。利多卡因注射仅显著延长 LA CL,解释了 LA 到 RA 的频率梯度的消失。持续性 AF 患者局部心房电图 CL 延长的机制尚不清楚。
J Cardiovasc Electrophysiol. 2007-1
J Thorac Cardiovasc Surg. 2009-9-9
J Cardiovasc Electrophysiol. 2011-4-13
Methodist Debakey Cardiovasc J. 2015
Heart Rhythm. 2020-11
J Am Heart Assoc. 2019-5-21
Pacing Clin Electrophysiol. 2017-6
J Am Coll Cardiol. 2016-9-13
JACC Clin Electrophysiol. 2015
J Am Coll Cardiol. 2014-8-26